STI-6129 not checked

Zhejiang ACEA Pharmaceutical Co. Ltd. · Sorrento Therapeutics, Inc. · Anti-CD38 antibody drug conjugate

FollowEvery change as it happens, and a Monday email
Stage
 
Next date
Phase 1/2 trial completes
Trials
1 active
5 in total
Targets
 

What this is

How it works
How it works isn't classified yet
How it’s given
“Anti-CD38 A2 human antibody drug conjugate (ADC) containing an antibody covalently bound to a duostatin tubulin inhibitor.”In the company’s words, NCT05565807 on ClinicalTrials.gov
Tested for
Relapsed or Refractory Multiple Myeloma
Main trialPhase 1/2
“This is a phase Ib/IIa, open-label, dose-escalation, and extension study to evaluate the safety and efficacy of an anti-CD38 antibody drug conjugate (STI-6129) in patients with relapsed or refractory multiple myeloma.”In the company’s words, NCT05565807 on ClinicalTrials.gov
Other names
Anti-CD38 antibody drug conjugate

Other drugs for Relapsed or Refractory Multiple Myeloma

All 266 drugs for Relapsed or Refractory Multiple Myeloma

Coming up1

Changes0

Last 90 days

No changes yet. We started recording changes on 6 Nov 2026.

Trials5

TrialPhaseCompletesWhat it tests
Phase 1/2Recruiting 31 Dec 2026 Safety and Efficacy Study of An Anti-CD38 Antibody Drug Conjugate in Relapsed or Refractory Multiple Myeloma
Phase 1/2Unknown Sep 2024 Study of the Safety and Efficacy of STI-6129 in Patients With Relapsed or Refractory Systemic AL Amyloidosis
Phase 1/2Unknown Dec 2025 Study to Assess Anti-CD38 Antibody Drug Conjugate in Relapsed or Refractory Multiple Myeloma
Phase 1Withdrawn Sep 2024 An Open-Label Study of the Safety of an Anti-CD38 Antibody Drug Conjugate (STI-6129) in Patients With AL Amyloidosis
Phase 1Unknown Aug 2025 Study to Access Anti-CD38 Anibody Drug in Patients With Advanced Solid Tumors
A trial in both registries shows both numbers.

About

Sources
ClinicalTrials.gov updated 18 Nov 2026 · EU trials register (CTIS) updated 18 Nov 2026 · openFDA updated 17 Nov 2026

Follow STI-6129

Following is part of Solo: you see every change to STI-6129 the day it happens.

Solo

$49a month, excl. VAT

  • Follow up to 5 landscapes, companies or drugs
  • Every change, the day it happens
  • A Monday email with the week’s changes
Choose Solo

Free

$0no card

  • One landscape of your own, in full
  • The top 10 of everything else
Sign up free

Have an account? Sign in